0001209191-23-016708.txt : 20230307 0001209191-23-016708.hdr.sgml : 20230307 20230307160825 ACCESSION NUMBER: 0001209191-23-016708 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230303 FILED AS OF DATE: 20230307 DATE AS OF CHANGE: 20230307 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Inbar Galia CENTRAL INDEX KEY: 0001878086 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-16174 FILM NUMBER: 23712664 MAIL ADDRESS: STREET 1: C/O TEVA STREET 2: 5 BASEL STREET, P.O. BOX 3190 CITY: PETACH TIKVA STATE: L3 ZIP: 4951033 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TEVA PHARMACEUTICAL INDUSTRIES LTD CENTRAL INDEX KEY: 0000818686 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L3 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5 BAZEL ST STREET 2: P O B 3190 CITY: PETACH TIKVA STATE: L3 ZIP: 49131 BUSINESS PHONE: 9729267267 MAIL ADDRESS: STREET 1: TEVA PHARMACEUTICAL INDUSTRIES LIMITED STREET 2: 5 BAZEL ST PO B 3190 CITY: PETACH TIKVA STATE: L3 ZIP: 49131 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2023-03-03 0 0000818686 TEVA PHARMACEUTICAL INDUSTRIES LTD TEVA 0001878086 Inbar Galia C/O TEVA PHARMACEUTICAL INDUSTRIES LTD. 124 DVORA HANEVI'A ST., TEL AVIV L3 6944020 ISRAEL 0 1 0 0 See "Remarks" Ordinary Shares 2023-03-04 4 M 0 20107 A 40301 D Ordinary Shares 2023-03-05 4 M 0 5710 A 46011 D Restricted Share Units 2023-03-03 4 A 0 59760 0.00 A Ordinary Shares 59760 59760 D Restricted Share Units 2023-03-04 4 M 0 20107 0.00 D Ordinary Shares 20107 60321 D Restricted Share Units 2023-03-05 4 M 0 5710 0.00 D Ordinary Shares 5710 11422 D The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share. Restricted share units were granted on March 3, 2023, with 14,940 vesting on each of March 3, 2024, March 3, 2025, March 3, 2026, and March 3, 2027. Restricted share units were granted on March 4, 2022, with 20,107 vested on March 4, 2023, and 20,107 vesting on each of March 4, 2024, March 4, 2025, and March 4, 2026. Restricted share units were granted on March 5, 2021, with 5,710 vested on each of March 5, 2022 and March 5, 2023, 5,710 vesting on March 5, 2024, and 5,712 vesting on March 5, 2025. EVP, Chief Human Resources Officer and Corporate Affairs /s/ Dov Bergwerk as attorney-in-fact for Galia Inbar 2023-03-07